A Drug Company's Forced Sales, and a Family Feud in Shanghai

A family of biotech contracting companies in Wuxi has begun selling offshore assets under pressure from Western governments worried about national security. Will other Chinese drugmakers with overseas assets be forced to follow suit? And a family feud in Shanghai has left a $1 billion luxury villa complex in limbo. How much risk does this kind of feuding pose for investors in the many publicly traded Chinese companies dominated by a single family?